New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
07:39 EDTCLDXCelldex CDX-1127 data positive, says Oppenheimer
After analyzing ASCO abstracts, Oppenheimer thinks the data indicated that Celldex's CDX-1127 is well-tolerated and capable of inducing an immune response. The firm keeps an Outperform rating on the stock.
News For CLDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
08:17 EDTCLDXCelldex says varlilumab demonstrated synergistic anti-tumor activity with PD-1
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use